These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34956868)

  • 1. Clinical Significance and Prognostic Value of the Maximum Standardized Uptake Value of
    Yin YX; Xie MZ; Liang XQ; Ye ML; Li JL; Hu BL
    Front Oncol; 2021; 11():741612. PubMed ID: 34956868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between 18F-FDG PET/CT Scans and KRAS Mutations in Metastatic Colorectal Cancer.
    Kawada K; Toda K; Nakamoto Y; Iwamoto M; Hatano E; Chen F; Hasegawa S; Togashi K; Date H; Uemoto S; Sakai Y
    J Nucl Med; 2015 Sep; 56(9):1322-7. PubMed ID: 26135109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of
    Arslan E; Aksoy T; Gürsu RU; Dursun N; Çakar E; Çermik TF
    Mol Imaging Radionucl Ther; 2020 Feb; 29(1):17-24. PubMed ID: 32079384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between PET/CT images and KRAS gene mutations in colorectal cancer in Vietnamese patients.
    Dan NV; Phuong PC; Thai PV; Nguyen NH; Loi NT; Cong BT
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1480-1486. PubMed ID: 36876696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between PET/CT parameters and KRAS expression in colorectal cancer.
    Chen SW; Chiang HC; Chen WT; Hsieh TC; Yen KY; Chiang SF; Kao CH
    Clin Nucl Med; 2014 Aug; 39(8):685-9. PubMed ID: 24978328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of ¹⁸F-FDG PET-CT maximum standard uptake value and T/N ratio with the prognosis of postoperative colorectal cancer].
    Wang X; Peng G; Zhang X; Chen Z; Zhang B; Li Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Mar; 18(3):232-7. PubMed ID: 25809325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insight on the correlation of metabolic status on
    Wang Y; Zhao N; Wu Z; Pan N; Shen X; Liu T; Wei F; You J; Xu W; Ren X
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1127-1136. PubMed ID: 31502013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations between maximum standardized uptake value measured via
    Li H; Wang X; Zhang L; Yi X; Qiao Y; Jin Q
    J Cancer Res Ther; 2019; 15(7):1581-1588. PubMed ID: 31939441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation of
    Qu YH; Long N; Ran C; Sun J
    Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between KRAS mutation and
    Cho A; Jo K; Hwang SH; Lee N; Jung M; Yun M; Hwang HS
    Abdom Radiol (NY); 2017 Jun; 42(6):1621-1626. PubMed ID: 28161825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUVmax and metabolic tumor volume: surrogate image biomarkers of KRAS mutation status in colorectal cancer.
    Lv Y; Wang X; Liang L; Wang L; Lu J
    Onco Targets Ther; 2019; 12():2115-2121. PubMed ID: 30962693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
    Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
    Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/computed Tomography in the Follow-up of Colorectal Cancer: Searching off Approaches Increasing Specificity for Detection of Recurrence.
    Ince S; Okuyucu K; Hancerliogulları O; Alagoz E; San H; Arslan N
    Radiol Oncol; 2017 Dec; 51(4):378-385. PubMed ID: 29333115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT texture analysis for the prediction of KRAS mutation status in colorectal cancer via a machine learning approach.
    Taguchi N; Oda S; Yokota Y; Yamamura S; Imuta M; Tsuchigame T; Nagayama Y; Kidoh M; Nakaura T; Shiraishi S; Funama Y; Shinriki S; Miyamoto Y; Baba H; Yamashita Y
    Eur J Radiol; 2019 Sep; 118():38-43. PubMed ID: 31439256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships of
    Sengoz T; Karakaya YA; Gultekin A; Yaylali O; Senol H; Yuksel D
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):32-38. PubMed ID: 34991834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations among KRAS Mutation, Microsatellite Instability, and 18F-FDG Uptake in Colon Cancer.
    Lee SS; Choi SJ; Park JS
    Asian Pac J Cancer Prev; 2022 Oct; 23(10):3501-3506. PubMed ID: 36308376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.